Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually.
Wondering what this means for the people you serve?
Genoa Healthcare recently hosted a webinar to discuss risk factor associated with TD, diagnostic criteria and assessment of TD, and approaches to managing and mitigating the symptoms. The webinar also covered costs and clinical outcomes of treatment options for consumers living with TD.
Watch the recording here:
Let’s talk
Reliable, full-service pharmacy care
Interested in learning more about how Genoa can help support your consumers living with tardive dyskinesia? Contact us today and we’ll be in touch.
"*" indicates required fields